comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 21:35:26 - browse：84777

Silas Buchanan, CEO of OurHealthyCommunity, speaks on a panel about democratizing clinical trials at the Milken Institute 2024 Global Conference on May 8, 2024 as Michelle McMurry-Heath, CEO of Biotechquity Clinical looks on. Milken Institute

Even with the recent awareness that clinical trials often lack the diversity that would make them representative, women and people of color remain underrepresented in studies. The work of bringing diversity to research is complex, and several experts gathered at the Milken Institute Global Conference on Wednesday to discuss potential strategies to make progress, starting with ways to build trust among the communities that have a history of being mistreated or exploited by the scientific community. Here are some of their big ideas.

Take the time to build trust

“What it’s going to take is to continue to develop the level of trust, it’s to continue to break down barriers,” said Fabian Sandoval, president and CEO of the Emerson Clinical Research Institute, which involves community clinics in trials with the goal of diversifying clinical research. “It’s for us physicians to take off our lab coats, take off the bow tie, and talk normal to people.”

Doing so, he said, requires a currency that is very scarce in health care: time. Doctors and researchers working on clinical trials need to invest time to build direct relationships with their patients, remind them that they are at liberty to quit the trial at any time (which could paradoxically help to increase retention), and still be cared for as patients.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

hotspot

focus

WSS

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Alabama hospital puts IVF treatments on hold

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

The Harvard botanist who searched for psychedelics in the Amazon

A new nitrogen execution bill also undermines medical licensing

entertainment

comprehensive

Take the time to build trust

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Novavax promises a turnaround & Lilly roils the obesity market

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

BioMarin wins approval for gene therapy to treat hemophilia A

A timeline of the missing Titanic tourist submersible

Apple is now the first public company to be valued at $3 trillion

Russians and Belarusians back at Wimbledon as war in Ukraine continues

ChatGPT in medicine: STAT answers readers' burning questions

Noem? Reynolds? A very early look at the Republican 'veepstakes'

What does generative AI mean for health care? We asked experts

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

hotspot

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Ed Silverman on new gene therapies, biosimilars, coffee, and more

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

NASA releases new images of 'fingerprint

Elon Musk announces 'temporary limits' for reading Twitter posts

entertainment

hotspot

focus

Wikipedia